ADVANCES IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA @AAMDSIF
ADVANCES IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA  @AAMDSIF
Uploaded June 2024 | Updated September 2026, 1 day ago
From the 2024 International Bone Marrow Failure Scientific Symposium: ADVANCES IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

Featured speakers:
Morag Griffin, MBChB, FRCPath - St James’s University Hospital, UK
How to choose among C5 inhibitors

Regis Peffault de Latour, MD, PhD - Hôpital Saint Louis, FRANCE
Proximal inhibitors: add-on or monotherapy? Front-line or second line?

Camilla Frieri, MD - AORN S. Giuseppe Moscati Avellino, ITALY
Is there a role for transplant in PNH?

Ronald Taylor, PhD - UNIVERSITY OF VIRGINIA
Identifying therapeutic targets in the complement cascade

Pedro Prata, MD - Hôpital Saint Louis, FRANCE
Germline complement gene variants in PNH
ADVANCES IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIAPatient Panel Discussion: Life with PNHLiving with MDS (Adult) - 2022 Memphis Patient & Family ConferenceUnderstanding Higher Risk MDS and the Transition to AMLTransplantation for Bone Marrow Failure with Amy DeZern, MD, MS and Richard Childs, MDDr. Rory Shallis explains new FDA approval for imetelstatExpanded Access to Reblozyl® for Patients with Dr. Guillermo Garcia ManeroPNH and Non Transplant Therapies, from the 2023 New Haven Patient and Family ConferenceWhat is PNH?  Webinar recording with Dr. Caroline Piatek2022 Miami Patient and Family Hybrid Conference: PNH with Dr. Damian LaberTransplants for MDS and Severe Aplastic Anemia - 2023 Omaha Patient and Family Hybrid ConferenceThe Future of Clinical Trials for Bone Marrow Failure
AAMDSIF |

ADVANCES IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER